Holen Sie sich die Stockscreener-App
42.68
8.90%
-4.18
Schlusskurs vom Vortag:
$46.86
Offen:
$45.85
24-Stunden-Volumen:
571.00K
Relative Volume:
0.44
Marktkapitalisierung:
$2.62B
Einnahmen:
$362.27M
Nettoeinkommen (Verlust:
$-85.19M
KGV:
-29.43
EPS:
-1.45
Netto-Cashflow:
$-68.71M
1W Leistung:
-12.27%
1M Leistung:
-10.43%
6M Leistung:
+68.67%
1J Leistung:
+8.57%
1-Tages-Spanne:
$42.52
$46.21
1-Wochen-Bereich:
$42.52
$49.00
52-Wochen-Spanne:
$23.30
$57.88
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
42.68 | 2.87B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
476.27 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
188.23 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
575.16 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.89 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.90 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Eingeleitet | Stephens | Overweight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Twist Bioscience at Barclays Conference: Strategic Growth and Innovation - Investing.com
Emily Leproust Sells 2,423 Shares of Twist Bioscience (NASDAQ:TWST) Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) SVP Sells 935 Shares - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading Down 5.7% After Insider Selling - MarketBeat
Twist Bioscience Corp (TWST) Trading Down 4.49% on Mar 10 - GuruFocus
Citigroup Inc. Cuts Position in Twist Bioscience Corporation $TWST - MarketBeat
Can Twist Bioscience Corporation stock deliver consistent earnings growth2025 Price Action Summary & Weekly Sector Rotation Insights - Naître et grandir
Aug Breakouts: How sensitive is Twist Bioscience Corporation to inflationMarket Risk Analysis & Verified Stock Trade Ideas - baoquankhu1.vn
Twist Bioscience Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations - Markets Mojo
Twist Bioscience Corp (TWST) Stock Price Up 5.17% on Mar 4 - GuruFocus
Twist Bioscience at TD Cowen Conference: Strategic Expansion in Therapeutics - Investing.com
TWST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Twist Bioscience Corporation $TWST Shares Sold by Vanguard Group Inc. - MarketBeat
The Insider Report: The Two Way Tape Continues as Bears Hold Firm - Sahm
What is the target price for Twist Bioscience Corporation stockJuly 2025 Retail & Weekly High Return Forecasts - baoquankhu1.vn
Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 Optimism - Yahoo Finance
[Form 4] Twist Bioscience Corp Insider Trading Activity - Stock Titan
Twist Bioscience (TWST) CFO tax-related sale of 2,085 shares disclosed - Stock Titan
Tax withholding sale by Twist Bioscience (TWST) SVP Paula Green - Stock Titan
Tax-withholding sale: Twist Bioscience (TWST) officer disposes 844 shares - Stock Titan
Twist Bioscience Adds Invenra Bispecific Platform To Broaden Discovery Opportunity - Yahoo Finance
Twist Bioscience Corp. Hits Day Low of $46.04 Amid Price Pressure - Markets Mojo
ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025 - Benzinga
TWST (NASDAQ: TWST) proposed resale of 7,205 vested shares - Stock Titan
Dennis H. Cho files Form 144 to sell 844 shares (TWST) - Stock Titan
2,085-Share Rule 144 Notice for Twist Bioscience (NASDAQ: TWST) - Stock Titan
Insider sale notice at TWST (NASDAQ: TWST) — 1,465 shares planned - Stock Titan
Insider sales and restricted stock vesting — TWST (NASDAQ: TWST) - Stock Titan
Robert F. Werner sells TWST shares; restricted 1,693 shares vest (TWST) - Stock Titan
Aug Gainers: Will Twist Bioscience Corporation stock benefit from M A2025 Earnings Impact & Daily Profit Focused Screening - baoquankhu1.vn
Twist Bioscience (TWST) Shares Dip as Executive Sells $2M in Sto - GuruFocus
Twist Bioscience (NASDAQ:TWST) Shares Gap DownWhat's Next? - MarketBeat
Twist Bioscience Corp (TWST) Stock Price Down 6.6% on Feb 20 - GuruFocus
Twist Bioscience stock falls after insider sale (TWST:NASDAQ) - Seeking Alpha
Insider Sell: Paula Green Sells 39,404 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience Corp (TWST) Trading Down 4.44% on Feb 19 - GuruFocus
Twist Bioscience (TWST) HR SVP sells 39,404 shares in open market - Stock Titan
Twist Bioscience to Present at Upcoming Investor Conferences - Business Wire
Twist Bioscience stock hits 52-week high at $51.02 By Investing.com - Investing.com India
Twist Bioscience enters licensing agreement with Invenra - TipRanks
Twist Bioscience Raises FY26 Revenue Forecast Exceeding Market Expectations - StocksToTrade
Twist Bioscience stock hits 52-week high at $51.02 - Investing.com
Twist Bioscience licenses Invenra’s bispecific antibody platform - Investing.com
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement - Business Wire
Insider Sell: Adam Laponis Sells 7,000 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 5,000 Shares - MarketBeat
Patrick Finn of Twist Bioscience (TWST) files to sell 3,500 shares under Rule 144 - Stock Titan
Insider plans 7,000-share Twist Bioscience (TWST) sale under Form 144 - Stock Titan
Twist Bioscience Corporation (NASDAQ:TWST) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
TWST stock (NASDAQ: TWST) holder plans 5,000-share sale filing - Stock Titan
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes - Business Wire
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Twist Bioscience Corp-Aktie (TWST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cho Dennis | See Remarks |
Mar 06 '26 |
Sale |
46.43 |
425 |
19,731 |
138,257 |
| Green Paula | SVP of Human Resources |
Mar 06 '26 |
Sale |
46.43 |
935 |
43,408 |
124,401 |
| Leproust Emily M. | Chief Executive Officer |
Mar 06 '26 |
Sale |
46.43 |
2,423 |
112,490 |
860,629 |
0.87%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):